US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 733 actively recruiting studies with Texas sites out of 733 registered in total. The busiest research areas in Texas are Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, The University of Texas Health Science Center, Houston. By stage, Texas trials break down as Phase 1 (194), Phase 2 (218), Phase 3 (133), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
733
Recruiting Now
733
← Back to US Map
Top Conditions in Texas
Colorectal Cancer (16)Ovarian Cancer (15)Advanced Solid Tumor (15)Prostate Cancer (14)Advanced Solid Tumors (12)Solid Tumor (11)Breast Cancer (11)Cancer (10)Heart Failure (9)Acute Myeloid Leukemia (9)Schizophrenia (9)Obesity (9)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 733 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 733. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT07551583 Phase 2
Recruiting
Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult P...
Condition
Hodgkin Lymphoma
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06657222 Phase 1, Phase 2
Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
250 pts
Location
United States, Canada, France
Sponsor
Gilead Sciences
View Trial →
NCT06287229 Phase 1, Phase 2
Recruiting
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene A...
Condition
Relapsed/Refractory
Enrollment
40 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT03767595 N/A
Recruiting
ProACT Post-Approval Study
Condition
Stress Urinary Incontinence
Enrollment
145 pts
Location
United States
Sponsor
Uromedica
View Trial →
NCT07782957 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared...
Condition
Nasal Polyps
Enrollment
218 pts
Location
United States, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Argentina, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT07197645 Phase 1
Recruiting
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Condition
Bone Pain
Enrollment
33 pts
Location
United States
Sponsor
Telix Pharmaceuticals (Innovat
View Trial →
NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With ...
Condition
Schizophrenia
Enrollment
100 pts
Location
United States
Sponsor
Neurocrine Biosciences
View Trial →
NCT07840365 Phase 3
Recruiting
Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage ...
Condition
Atrial Fibrillation (AF)
Enrollment
234 pts
Location
United States
Sponsor
Texas Cardiac Arrhythmia Resea
View Trial →
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult P...
Condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Enrollment
116 pts
Location
United States, Spain, Switzerland
Sponsor
Debiopharm International SA
View Trial →
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
View Trial →
NCT07779798 Phase 1
Recruiting
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, a...
Condition
Advanced Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
Crossbow Therapeutics, Inc.
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05726292 Phase 2
Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant...
Condition
Prostate Cancer
Enrollment
90 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT05968664 N/A
Recruiting
Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulati...
Condition
Chronic Pain
Enrollment
43 pts
Location
United States
Sponsor
Ashwin Viswanathan
View Trial →
NCT07523581 Phase 2
Recruiting
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exalur...
Condition
Alport Syndrome, X-Linked
Enrollment
24 pts
Location
United States, United Kingdom
Sponsor
Eloxx Pharmaceuticals, Inc.
View Trial →
NCT05487911 N/A
Recruiting
Cortical rTMS as a Treatment for Depression
Condition
Major Depressive Disorder
Enrollment
50 pts
Location
United States
Sponsor
Baylor College of Medicine
View Trial →
NCT05759299 N/A
Recruiting
International obServational sTudy on AiRway manaGement in operAting Room and Non...
Condition
Airway Complication of Anesthesia
Enrollment
10,500 pts
Location
United States, France, India
Sponsor
University of Turin, Italy
View Trial →
NCT07293754 Phase 1, Phase 2
Recruiting
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
Condition
Advanced Malignant Solid Tumor
Enrollment
150 pts
Location
United States, Ireland, Portugal
Sponsor
Repertoire Immune Medicines
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT06345495 Phase 2
Recruiting
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis ...
Condition
Splenomegaly
Enrollment
30 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07266831 Phase 2, Phase 3
Recruiting
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have No...
Condition
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Enrollment
570 pts
Location
United States, Argentina, Canada
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 2 of 30 — 733 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology